共 50 条
- [43] Commentary: SGLT inhibitors in type 1 diabetes: Place in therapy and a risk mitigation strategy for preventing diabetic ketoacidosis - the STOP DKA protocol DIABETES OBESITY & METABOLISM, 2019, 21 (10): : 2189 - 2191
- [44] SLEEPOVERS AND DIABETIC KETOACIDOSIS: A CROSS SECTIONAL CHART REVIEW OF DKA ADMISSIONS IN ESTABLISHED PATIENTS WITH TYPE 1 DIABETES HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 400 - 401